BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

8:57 AM
 | 
Jan 12, 2018
 |  BC Week In Review  |  Company News  |  Deals

Fosun gets Chinese rights to Bial's PD drug

Bial-Portela & Ca. S.A. (S. Mamede do Coronado, Portugal) granted the Jiangsu Wanbang Biopharmaceutical Group Co. Ltd. subsidiary of Shanghai Fosun Pharmaceutical Group Co. Ltd. (Shanghai:600196; HKSE:2196) exclusive, Chinese...

Read the full 122 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >